scorecardresearch
Add as a preferred source on Google
Monday, August 10, 2026
TopicModerna Inc.

Topic: Moderna Inc.

1st mRNA flu vaccine gets FDA nod after rare U-turn. What the technology does & why it faced scrutiny

Moderna’s mFLUSIVA is the first mRNA vaccine approved for seasonal flu. Its route to approval was unusual, with the FDA initially rejecting the application before reversing course.

Moderna sues Pfizer, BioNTech for infringing its Covid vaccine patent

The company said the rival vaccine makers breached patents that covered its ‘foundational mRNA technology’.

Pfizer’s Covid vaccine safe & effective for children under 5, says US FDA

A lower rate of adverse reactions was seen in trials of the youngest kids, compared with trials of older age groups, the Food and Drug Administration (FDA) report said.

Close to commit over $1 billion advance to Moderna for Covid booster vaccine: Cipla to govt

Cipla's communication to the govt follows a recent high-level meeting during which it was discussed that Moderna has proposed to launch a single-dose vaccine for the Indian market.

Moderna in talks with Cipla, likely to launch single-dose Covid vaccine in India in 2022

While US giant Pfizer is ready to offer 5 crore shots in 2021 itself but it wants significant regulatory relaxations including indemnification, sources said Tuesday.

Pfizer, Moderna Covid vaccines 90% effective after 2 doses in ‘real-world’ use: US Study

According to data from US Centers for Disease Control & Prevention, Pfizer & Moderna Covid vaccines effectively prevented infections, not just illness, with substantial protection.

Qatar approves emergency use of Moderna shot, Hong Kong to ease restrictions & other Covid news

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

CSIR in talks to bring Moderna’s Covid vaccine to India, says its chief Shekhar Mande

Mande says current talks are scientific, and once CSIR’s Hyderabad-based CCMB understands Moderna’s mRNA technology, it can produce the vaccine ‘within weeks’.

Vaccine maker IIL, other companies in touch with Moderna to bring its Covid vaccine to India

Research organisation Centre for Cellular & Molecular Biology is acting as mediator between the Indian companies & American vaccine maker Moderna Inc.

Moderna vaccine gets EU approval as bloc faces pressure to scale up Covid efforts

The 27-nation bloc began immunisations last week with vaccine developed by Pfizer & BioNTech, but the pace of the rollout has been uneven, prompting comparisons with UK & US.

On Camera

India needs its own social media ecosystem, like China, South Korea and Russia

The government must also look at creating indigenous social media platforms with graded exposure to young people.

$92 mn to $609 mn: Andhra FDI inflows surged after Jagan-era slowdown, TDP credits policy reset

Data on FDI rise has become a political flashpoint, with Naidu govt projecting an investor-friendly turnaround while YSRCP leader says ‘unwarranted information’ provided in House.

And it’s official: India in talks with France to join 6th Gen fighter programme FCAS

In February this year, ThePrint reported that India is exploring the possibility of teaming up with France for co-development and co-manufacturing of the futuristic FCAS.

Guru RSS is cautioning shishya Modi govt. Bhagwat’s endorsement of Gen Z has an Indira lesson

It’s evident Bhagwat was watching from a distance and was worried about youth’s anger towards Modi govt. The first thing he did was to demolish any criticism of Gen Z protesters as anti-national.